Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.665
-0.035 (-2.06%)
Apr 29, 2026, 1:24 PM EDT - Market open
Pyxis Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 15.42 | 19.47 | 9.66 | 179.29 | 274.74 | Upgrade
|
| Short-Term Investments | 51.44 | 107.46 | 109.63 | - | - | Upgrade
|
| Cash & Short-Term Investments | 66.86 | 126.93 | 119.3 | 179.29 | 274.74 | Upgrade
|
| Cash Growth | -47.33% | 6.40% | -33.46% | -34.74% | 3300.19% | Upgrade
|
| Other Receivables | 0.7 | - | - | 0.6 | - | Upgrade
|
| Receivables | 0.7 | - | - | 0.6 | - | Upgrade
|
| Prepaid Expenses | 0.59 | 0.76 | 1.01 | 1.31 | 1.76 | Upgrade
|
| Restricted Cash | 1.47 | 1.47 | 1.47 | 1.47 | 1.47 | Upgrade
|
| Other Current Assets | 2.49 | 3.28 | 2.82 | 3.94 | 0.7 | Upgrade
|
| Total Current Assets | 72.11 | 132.44 | 124.6 | 186.61 | 278.67 | Upgrade
|
| Property, Plant & Equipment | 19.42 | 22.14 | 24.81 | 24.77 | 1.24 | Upgrade
|
| Other Intangible Assets | - | 2.6 | 24.31 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | - | 0.11 | Upgrade
|
| Total Assets | 91.52 | 157.18 | 173.73 | 211.38 | 280.02 | Upgrade
|
| Accounts Payable | 10.89 | 4.86 | 3.9 | 7.1 | 11.95 | Upgrade
|
| Accrued Expenses | 8.12 | 10.73 | 12.62 | 23.45 | 6.33 | Upgrade
|
| Current Portion of Leases | 1.69 | 1.45 | 1.23 | - | 0.17 | Upgrade
|
| Current Unearned Revenue | - | - | 7.66 | - | - | Upgrade
|
| Other Current Liabilities | 0.43 | 0.64 | 0.36 | 1.09 | 0.27 | Upgrade
|
| Total Current Liabilities | 21.13 | 17.68 | 25.76 | 31.63 | 18.71 | Upgrade
|
| Long-Term Leases | 16.98 | 18.75 | 20.1 | 18.92 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 2.16 | - | - | Upgrade
|
| Total Liabilities | 38.11 | 36.43 | 48.02 | 50.56 | 18.71 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.05 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 496.47 | 484.08 | 411.82 | 373.23 | 353 | Upgrade
|
| Retained Earnings | -443.18 | -363.56 | -286.23 | -212.44 | -91.72 | Upgrade
|
| Comprehensive Income & Other | 0.05 | 0.17 | 0.06 | - | - | Upgrade
|
| Total Common Equity | 53.41 | 120.75 | 125.7 | 160.82 | 261.31 | Upgrade
|
| Shareholders' Equity | 53.41 | 120.75 | 125.7 | 160.82 | 261.31 | Upgrade
|
| Total Liabilities & Equity | 91.52 | 157.18 | 173.73 | 211.38 | 280.02 | Upgrade
|
| Total Debt | 18.67 | 20.2 | 21.33 | 18.92 | 0.17 | Upgrade
|
| Net Cash (Debt) | 48.18 | 106.73 | 97.97 | 160.37 | 274.57 | Upgrade
|
| Net Cash Growth | -54.85% | 8.95% | -38.91% | -41.59% | 3661.23% | Upgrade
|
| Net Cash Per Share | 0.78 | 1.83 | 2.46 | 4.85 | 32.33 | Upgrade
|
| Filing Date Shares Outstanding | 62.83 | 61.59 | 58.13 | 36.83 | 32.22 | Upgrade
|
| Total Common Shares Outstanding | 62.69 | 59.97 | 44.75 | 34.96 | 32.17 | Upgrade
|
| Working Capital | 50.97 | 114.76 | 98.85 | 154.98 | 259.97 | Upgrade
|
| Book Value Per Share | 0.85 | 2.01 | 2.81 | 4.60 | 8.12 | Upgrade
|
| Tangible Book Value | 53.41 | 118.15 | 101.4 | 160.82 | 261.31 | Upgrade
|
| Tangible Book Value Per Share | 0.85 | 1.97 | 2.27 | 4.60 | 8.12 | Upgrade
|
| Machinery | 4.15 | 4.19 | 4.52 | 3.28 | 1.9 | Upgrade
|
| Construction In Progress | - | - | - | 9.18 | - | Upgrade
|
| Leasehold Improvements | 10.74 | 10.74 | 10.96 | 0.53 | 0.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.